Department of Ophthalmology
Rabin Medical Center
Dr. Ruth Axer-Siegel is affiliated to Department of Ophthalmology, Rabin Medical Center, where Dr. Ruth Axer-Siegel is currently working as Professor. Dr. Ruth Axer-Siegel has authored and co-authored several national and international publications and also working as a reviewer for reputed professional journals. Dr. Ruth Axer-Siegel is having an active association with different societies and academies around the world. Dr. Ruth Axer-Siegel made his mark in the scientific community with the contributions and widely recognition from honourable subject experts around the world. Dr. Ruth Axer-Siegel has received several awards for the contributions to the scientific community. Dr. Ruth Axer-Siegel major research interest involves Ophthalmology and Medical Sciences.
Ophthalmology and Medical Sciences
Axer-Siegel R, Snir M, Ron Y, Friling R, Sirota L, Weinberger D. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity. Retina. 2011 Jul-Aug;31(7):1239-47.
Siegel RA, Dreznik A, Mimouni K, Bor E, Weinberger D, Bourla DH. Intravitreal bevacizumab treatment for macular edema due to branch retinal vein occlusion in a clinical setting. Curr Eye Res. 2012 Sep;37(9):823-9.
Axer-Siegel R, Dotan A, Mimouni K, Bor E, Weinberger D, Bourla DH. Intravitreous bevacizumab treatment for macular edema due to central retinal vein occlusion. Curr Eye Res. 2012 Sep;37(9):818-22.